Axalta (AXTA)

NYSE Materials Specialty Chemicals S&P MidCap 400
$36.45
+0.11 (+0.30%)
Close of Nov 06, 2026 · end-of-day data
Next earnings date
Not scheduled yet
No report date announced in the next three weeks.
Consensus EPS estimate
—
Shown once a date is announced.
Trailing 12-month EPS
$1.55
Diluted, last four reported quarters

Earnings surprise history

reported EPS vs consensus
ReportedQuarterEPS estimateReported EPSSurprise
Oct 29, 2026Sep/2026$0.71$0.63-11.3%

Our record of AXTA's reports since we began tracking; it grows each quarter.

Latest results, in brief

All AXTA 8-K briefs →
Oct 29, 7:10 AM ET

Axalta Q3 net sales rise 2% to $1.3 billion; net income falls to $95 million

Mixed earnings 2.02

Axalta reported third-quarter 2026 net sales of $1.3 billion, up 2% year over year, while net income fell $15 million to $95 million and diluted EPS dropped to $0.44 from $0.51. The company cited $14 million more in merger and acquisition-related expenses, tied to its proposed combination with AkzoNobel, and lower volumes in Performance Coatings. Shareholders also received fourth-quarter and full-year 2026 outlook figures, including full-year Adjusted EBITDA of $1,100 million to $1,110 million.

  • Q3 2026 net sales were $1.3 billion, up 2%; Adjusted EBITDA was $282 million, down 4%, with a 21.5% margin
  • Diluted EPS was $0.44 versus $0.51 a year earlier; Adjusted Diluted EPS was $0.63, down 6%
  • Mobility Coatings posted record quarterly net sales of $493 million; Performance Coatings Adjusted EBITDA fell to $188 million from $211 million
  • Outlook: Q4 2026 Adjusted EBITDA of $254 million to $264 million; full-year 2026 Adjusted EBITDA of $1,100 million to $1,110 million and Adjusted Diluted EPS of about $2.45
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.

Quarter endedRevenueYoYEPS (diluted)YoYNet incomeNet margin
Sep 2026$1.31B+1.8% $0.44-13.7% $95.00M7.2%
Jun 2026$1.35B+3.1% $0.41-18.0% $89.00M6.6%
Mar 2026$1.25B-0.6% $0.42-6.7% $90.00M7.2%
Dec 2025$1.26B-3.7% $0.28-55.6% $60.00M4.8%
Sep 2025$1.29B-2.4% $0.51+10.9% $110.00M8.5%
Jun 2025$1.30B-3.4% $0.50-2.0% $109.00M8.4%
Mar 2025$1.26B-2.5% $0.45+150.0% $99.00M7.8%
Dec 2024$1.31B+1.1% $0.63+85.3% $137.00M10.5%

From Axalta's 10-Q and 10-K filings (SEC XBRL). YoY compares each quarter with the same quarter a year earlier; it is blank when the year-ago figure is missing or negative.

Annual results

Fiscal yearRevenueGrowthEPS (diluted)GrowthNet margin
FY2025$5.12B-3.0% $1.74-2.2%7.4%
FY2024$5.28B+1.8% $1.78+47.1%7.4%
FY2023$5.18B+6.1% $1.21+40.7%5.2%
FY2022$4.88B+10.6% $0.86-24.6%3.9%
FY2021$4.42B+18.2% $1.14+119.2%6.0%

Frequently asked questions

When is Axalta's next earnings date?

Axalta has not announced a report date within the next three weeks. US companies usually report three to six weeks after each quarter ends; this page updates as soon as the date is on the calendar.

What did Axalta earn last quarter?

For the quarter ended Sep 2026, Axalta reported diluted EPS of $0.44 (-13.7% year over year) on revenue of $1.31B (+1.8%).

Where do these numbers come from?

Reported revenue, net income and EPS come from the company's own 10-Q and 10-K filings with the SEC (XBRL data). The report date and consensus estimate come from the Nasdaq earnings calendar.

Not investment advice. Figures can be restated by the company in later filings.